Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 35, 2025
Staying with you through milestone moments at Qiming Venture Partners portfolio companies
启明创投
@author-1788515151757110
启明创投致力于成为中国优秀技术创业者们的首选投资机构
345 articles
Articles
Qiming Stars | Seven-Nation Permit, World's Only! WeRide Robobus Secures Belgium's First L4 Autonomous Driving License
As an autonomous driving technology company, WeRide's ultimate goal has always been to achieve safe and reliable Level 4 fully driverless operations. Securing the Belgium autonomous driving test permit is a critical step toward this goal, demonstrating the company's technical capabilities in real-world road scenarios and setting a benchmark for more European countries to open up autonomous driving testing.
AusperBio raises $63M in Series B2 funding co-led by Qiming Venture Partners
Haibo Pharmaceutical is a clinical-stage innovative drug company focused on the R&D of self-developed targeted small nucleic acid therapeutics, with "achieving clinical cure for chronic hepatitis B" as its core mission.
Qiming Venture Partners Selected for China Fund Times Second Annual Private Equity and Venture Capital Yinghua Demonstration Cases
The awards aim to establish industry benchmarks for venture capital and private equity, broaden public awareness of equity investment, and promote the sector's standardized development.
Qiming ESG | Crafting a New Future from Plastic Waste — Qiming Venture Partners Hosts Upcycling Workshop
This initiative aligns closely with multiple United Nations Sustainable Development Goals (SDGs). Through a hybrid format combining hands-on practice and educational outreach, employees gain immersive understanding of the value of circular economy principles — giving discarded materials a "second life."
Qiming Venture Partners portfolio company WeRide officially enters its 11th global market, deploying autonomous Robobus in Belgium
After completing testing and receiving approval as scheduled, the partner expects to launch a trial operation between mid-November 2025 and late January 2026, which would mark Belgium's first commercial deployment of autonomous vehicles in mixed, complex traffic environments.
Qiming Venture Partners and Its Investors Named to 36Kr's 2025 China Industrial Investors Annual List
The list aims to identify investment firms and investors who embrace patience and foresight, and who are putting their convictions into practice to inject the strongest possible momentum into industries of the future.
Qiming Venture Partners' Portfolio Company Hesai Technology Completes Dual Primary Listing on Hong Kong Exchanges and Clearing Limited
Qiming Venture Partners has long paid close attention to innovation and transformation in the autonomous driving space. In 2019, Qiming Venture Partners participated in Hesai Technology's Series C financing and continued to invest in its Series D round.
Qiming Venture Partners Weekly | Portfolio Company Updates Vol. 34, 2025
Tracking milestone moments with you for Qiming Venture Partners' portfolio companies
Qiming Portfolio Company Yanyin Technology Partners with HEC Pharm on Strategic AI Collaboration
The two parties will engage in in-depth collaboration on AI agent R&D, using the AI translation agent project as a starting point to develop solutions covering core scenarios including experimental design and IND filing, as well as AI laboratory automation robotics. Together, they will explore the deep application of AI technology across the full drug discovery and development pipeline, accelerating the globalization strategy of East Sunshine Pharmaceutical.